Showing results (121-130 of 956) with videos related to
Sort By:
Pageof 96
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 18, 2007
BDNF variant linked to anxiety-related behaviorsKenji HashimotoBiochemical Pharmacology|April 1, 2020
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamineKenji HashimotoBrain and Nerve = Shinkei Kenkyu No Shinpo|October 19, 2017
[Biomarkers for Mood Disorders and a Novel Antidepressant (R)-ketamine]Kenji HashimotoExpert Opinion on Therapeutic Targets|September 21, 2016
Ketamine's antidepressant action: beyond NMDA receptor inhibitionKenji HashimotoJournal of Pharmacological Sciences|February 24, 2015
Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implicationKenji HashimotoProgress in Brain Research|July 6, 2023
Neuroinflammation through the vagus nerve-dependent gut-microbiota-brain axis in treatment-resistant depressionKenji HashimotoFrontiers in Pharmacology|February 15, 2019
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological DisordersKenji HashimotoPsychiatry and Clinical Neurosciences|July 27, 2010
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directionsKenji HashimotoProgress in Neurobiology|October 10, 2012
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depressionKenji HashimotoEuropean Archives of Psychiatry and Clinical Neuroscience|February 27, 2024
Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?Kenji HashimotoPageof 96